Personal Injury Resources

I would like to see the trial data, too. How else can you decide how bad the risks from these Cox-2 inhibitors are?

Pfizer has withdrawn the COX-2 inhibitor Bextra off the market under FDA pressure. They are also putting a “black box” warning on their older drug Celebrex, which is now the only COX-2 inhibitor left on the U.S. market, since Merck withdrew Vioxx last year under similar pressure.

The fact that the information is not yet public is part of the problem. It appears that the FDA would rather have you suffer indescribable pain and be bedridden with arthritis (for example), than have you run a slight risk of a heart attack. (A risk which you might be able to mitigate with exercise, that you can’t get without athritis medicine.) Or to put it a different way, they’d rather you die of a bleeding ulcer from taking too much aspirin or ibuprofen, than die of a heart attack from taking Bextra or Vioxx. I don’t doubt...

Related Products: Visit our store

Read more from this blogger: Pfizer Withdraws Painkiller Bextra